The National Institutes of Health has awarded Cold Spring Harbor Laboratory, Caltech, Emory University, Georgia Institute of Technology, The German Cancer Research Center, the Medical College of Georgia, MIT, and New York University Medical Center a five-year, $10 million grant to establish a Nanomedicine Center for Nucleoprotein Machines. The center will initially focus on understanding the molecular machines that enable cells to detect and repair damaged DNA. Defects in the repair of damaged DNA cause or contribute to many human diseases, including cancer. Professor David Spector will lead Cold Spring Harbor Laboratory's contributions to the center's research, which will involve multidisciplinary scientific teams comprising biologists, physicians, mathematicians, biomolecular engineers, and computer scientists. The Nanomedicine Center for Nucleoprotein Machines is a key part of the NIH's goal to explore the potential uses of nanotechnology in medicine.